Showing results (61-70 of 183) with videos related to

Sort By:
Pageof 19
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 18, 2022
Delivery strategies of RNA therapeutics to leukocytesDana Tarab-Ravski, Lior Stotsky-Oterin, Dan Peer
Cancer Letters|October 15, 2008
Treatment of resistant human colon cancer xenografts by a fluoxetine-doxorubicin combination enhances therapeutic responses comparable to an aggressive bevacizumab regimenMirit Argov, Rina Kashi, Dan Peer, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|September 27, 2015
Platelet mimicry: The emperor's new clothes?Seyed Moein Moghimi, Alan Christy Hunter, Dan Peer
Advanced Drug Delivery Reviews|July 14, 2020
Progress and challenges towards CRISPR/Cas clinical translationDaniel Rosenblum, Anna Gutkin, Niels Dammes, et al.
Toxins|August 23, 2016
A Simple Luminescent Adenylate-Cyclase Functional Assay for Evaluation of Bacillus anthracis Edema Factor ActivityMa'ayan Israeli, Shahar Rotem, Uri Elia, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 18, 2019
Systemic Modulation of Lymphocyte Subsets Using siRNAs Delivered via Targeted Lipid NanoparticlesInbal Hazan-Halevy, Daniel Rosenblum, Srinivas Ramishetti, et al.
Scientific Reports|August 8, 2019
Inhibition of Francisella tularensis phagocytosis using a novel anti-LPS scFv antibody fragmentAdva Mechaly, Uri Elia, Ron Alcalay, et al.
Frontiers in Immunology|October 31, 2025
The mRNA component of LNP-mRNA vaccines triggers IFNAR-dependent immune activation which attenuates the adaptive immune responseLiat Bar-On, Hila Cohen, Uri Elia, et al.
Cancer Letters|April 30, 2013
eIF3c: a potential therapeutic target for cancerRafi Emmanuel, Shiri Weinstein, Dalit Landesman-Milo, et al.
Nano Letters|May 25, 2021
Lipid Nanoparticle RBD-hFc mRNA Vaccine Protects hACE2 Transgenic Mice against a Lethal SARS-CoV-2 InfectionUri Elia, Shahar Rotem, Erez Bar-Haim, et al.
Pageof 19